Friday, February 3, 2023
HomeLatest Pharma-NewsAcquisition of Neogene Therapeutics completed

Acquisition of Neogene Therapeutics completed

January 16, 2023: “AstraZeneca has completed the acquisition of Neogene Therapeutics Inc. (Neogene), a global clinical-stage biotechnology company pioneering the discovery, development and manufacturing of next-generation T-cell receptor therapies (TCR-Ts).

Neogene will operate as a wholly owned subsidiary of AstraZeneca, with operations in Amsterdam, the Netherlands and California, US.

- Advertisement -

Financial considerations
AstraZeneca has acquired all outstanding equity of Neogene in exchange for an initial payment of $200m.

Under the terms of the agreement, AstraZeneca will pay up to $120m in additional contingent milestone-based and non-contingent consideration.

https://www.astrazeneca.com/media-centre/press-releases/2023/acquisition-of-neogene-therapeutics-completed.html

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisment -

Most Popular